Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7
New position
Shares Held
500
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#322
of 323 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Forum Finance Group S.A. holds $1,667 across 13 Biotechnology names. NTLA ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTN |
Palatin Technologies Inc
|
92 | $992 | |
| 2 | MRNA |
Moderna, Inc.
|
10,000 | $566 | |
| 3 | RNAC |
Cartesian Therapeutics, Inc.
|
3,900 | $33 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
750 | $33 | |
| 5 | ARGX |
Argenx SE
|
12 | $9 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
2,500 | $7 | |
| 7 | NTLA |
Intellia Therapeutics, Inc.
This page
|
500 | $7 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
200 | $6 |
All Filings in NTLA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7 | 500 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||